Your shopping cart is empty
Subscriber login
REGISTER FOR FREE EZINES
Advanced Search
- Please Select -
Return to the main site
Regulation
Business Development
Drug Manufacturing
Device Manufacturing
Quality Management
Return to the main site
Home
Books
Conferences
DVDs
Newsletters
Form 483
s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us
Check out our free and informative ezines and sign up now
Sign Up
Home
>
Newsletters
>
FDAnews Device Daily Bulletin
> FDA Requests Devicemakers’ Input on Off-Label Communication
FDAnews Device Daily Bulletin
Jan. 9, 2012
| Vol. 9 No. 5
FDA Requests Devicemakers’ Input on Off-Label Communication
In response to a citizen petition, the FDA is seeking public input on how it should regulate scientific exchanges on off-label uses for medical products.
Devices & Diagnostics Letter
Register Now
Print This Page
Email This Article
RSS
Archives
Related Articles
First IDE Approval to Heart Societies Goes to Study Off-Label Sapien Use
FDA Will Use
Caronia
to Develop New Guidance; No Further Appeals Planned
Fewer Warning Letters on Marketing Likely in Wake of
Caronia
Verdict
Defense Attorneys Predict No FDA Action on Caronia, but Off-Label Guidance Crucial